Global Age-Related Macular Degeneration Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 236

  • Format: PPT, PDF

Global Age-Related Macular Degeneration Market: Segmented by Type (Wet Age-Related Macular Degeneration (Wet AMD) and Dry Age-Related Macular Degeneration (Dry AMD)) by Stage, by Age Group, by Treatment (Treatment and Diagnosis) by Route of Administration (Intravitreal Route of Administration and Intravenous Route of Administration) by End User (Hospital & Clinics, Diagnostic Centres and Academic Research Institutes) & Region – Forecast till 2028.


Report Overview

The global age-related macular degeneration market size stood at around USD 8.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Growing geriatric population and increasing prevalence of age-related macular degeneration, several branded drugs going off-patent are expected to enhance market growth. However, factors such as high cost associated with AMD, stringent FDA regulations may restrain the market growth during the forecast period.

Market Drivers

Increasing government expenditure on healthcare to reduce healthcare burden on patients is one of the key growth drivers for the age-related macular degeneration market. Globally, healthcare burden has increased substantially and become a major concern for patients and healthcare providers. Expensive nature of advanced treatment methods and increasing physician fees are some of the factors leading to high healthcare costs. In view of this, governments of various countries have increased their overall expenditure on healthcare to facilitate accessibility to affordable treatment options. This, in turn, is supporting the market growth across the world.

Moreover, the extensive pipeline of AMD drugs is a key factor driving the age-related macular degeneration market. Although there are limited treatment options for AMD at present, key players in the industry are focused on developing drugs for this indication to meet the growing unmet medical needs of the patients suffering from the disease.

Type of Macular Degeneration

AMD is of two types; dry and wet AMD. Dry AMD is caused by the formation of deposits called under the retina; and, wet AMD is caused by abnormal growth of the blood vessels beneath the macula. Wet AMD accounts for larger share in the market owing to rising prevalence of this compared to dry AMD among the geriatric population. This segment also has a growth rate of 7% and is growing faster than the dry AMD segment.

1. Global Age-Related Macular Degeneration Market Overview…………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Growing Geriatric Population and Prevalence of Eye Disorders
B. Increase in Pipeline Drugs for AMD
3. Related Macular Degeneration type………………………………………………………………………….
A. Wet AMD
B. Dry EMD
4. Age-Related Macular Degeneration Market Segmentation……………………………
A. Route of Administration
I. Intravenous
II. Intravitreal
B. Drug Class
I. Lucentis
II. Eylea
III. Avastin
C. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Age-Related Macular Degeneration Products Market Share……………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. F. Hoffmann-La Roche Company overview, Product & Services, Strategies & Financials
B. Novartis Ag Company overview, Product & Services, Strategies & Financials
C. Pfizer Inc. Company profile, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Recent Development in the AMD Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Wet AMD has drugs for its treatment, whereas dry AMD has no available treatment. The drugs used for wet AMD include anti-Vascular Endothelial Growth Factor drugs (anti-VEGF). Commonly used drugs are Lucentis (ranibizumab) and Eylea (aflibercept) that are FDA-approved for the treatment of AMD. Off label drug Avastin (bevacizumab) is also popularly used. Photodynamic therapy (PDT) is also being used as a treatment for wet AMD and it slows the damage to vision.

By Region:

The global age-related macular degeneration market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominate the global age-related macular degeneration market is owing to the rising ophthalmological disorders and increasing aging population. Nearly 7.3 million people are at significant risk of vision loss due to AMD.

Europe holds the second largest market share due to increasing older population and rising patient population. Additionally, improving government initiatives and increasing healthcare frame along with growing demand for technologically innovative treatment is driving the growth of age-related macular degeneration market in Europe.

Asia-Pacific is estimated to be the fastest-growing region in the global age-related macular degeneration as it is developing at a very rapid pace and has shown the emergence of many players. Moreover, rising prevalence of eye disorders, increasing healthcare spending, and multinational companies moving towards the developing nations and setting operational set-ups are likely to drive the growth of the market. Japan held a market share of 23.2% in 2017.

The Middle East & Africa are expected to witness restricted growth due to limited access and healthcare affordability among the population. In the Middle East, the growth of the market is driven by increasing healthcare infrastructure and healthcare expenditure.

Key Players

The prominent players in the global age-related macular degeneration market are Novartis AG, Pfizer Inc, F. Hoffmann-La Roche AG, Acucela Inc., Ophthotech Corporation, GlaxoSmithKline PLC, Bayer AG, Rxi Pharmaceuticals, Inc., Regeneron Pharmaceutical Inc., Alimera Sciences Inc., Santen Pharmaceuticals Co., ALLERGAN, and Bausch & Lomb Incorporate.

The players operating in the global age-related macular degeneration market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

  • In September 2017, F. Hoffmann-La Roche AG announced the first lampalizumab phase III study for geographic atrophy owing to Age-Related Macular Degeneration (AMD)
  • In December 2016, Acucela entered into an R&D collaboration agreement with EyeMedics, LLC
  • In July 2017, Ophthotech Corporation announced its focus on clinical experience and retina expertise to introduce therapies to treat multiple orphan ophthalmic diseases


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements